Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
Alignment to the key priorities, the four core programs.
Quelle est la meilleure partie de votre programme de rémunération?
The salary is the best part of the compensation package.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
The ET has the best interest of the company in mind, aligned with the key priorities.
Quelles sont les meilleures choses à propos de votre équipe?
They all have the best intentions, doing what they can to make Karyopharm a better place.
Other Employee Reviews for Karyopharm Therapeutics
×